Tarsus Pharmaceuticals Inc banner

Tarsus Pharmaceuticals Inc
NASDAQ:TARS

Watchlist Manager
Tarsus Pharmaceuticals Inc Logo
Tarsus Pharmaceuticals Inc
NASDAQ:TARS
Watchlist
Price: 67.2 USD 0.36% Market Closed
Market Cap: $2.9B

Intrinsic Value

The intrinsic value of one TARS stock under the Base Case scenario is 97.36 USD. Compared to the current market price of 67.2 USD, Tarsus Pharmaceuticals Inc is Undervalued by 31%.

TARS Intrinsic Value
97.36 USD
Undervaluation 31%
Intrinsic Value
Price
Worst Case
Base Case
Best Case
Get notified when the price drop
Track Buy Zone
20% below Intrinsic Value $77.89
Get notified when the price drops into your buy zone
Intrinsic Value $97.36
Margin of Safety 20% $77.89
Current Price $67.2
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
Ask AI Assistant
What other research platforms think about TARS?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is TARS valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Tarsus Pharmaceuticals Inc.

Explain Valuation
Alternatives to TARS

Fundamental Analysis

Financials
Efficiency

Earnings Waterfall
Tarsus Pharmaceuticals Inc

Wall St
Price Targets

Dividends

Tarsus Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Competitive Landscape

Ownership

TARS Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one TARS stock?

The intrinsic value of one TARS stock under the Base Case scenario is 97.36 USD.

Is TARS stock undervalued or overvalued?

Compared to the current market price of 67.2 USD, Tarsus Pharmaceuticals Inc is Undervalued by 31%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett